Health Tech

πŸ‘©β€βš•οΈ Gates Foundation launches initiative to speed development of therapies for the coronavirus

The Bill & Melinda Gates Foundation, Wellcome, and Mastercard have committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments.

πŸ‘©β€βš•οΈ Gates Foundation launches initiative to speed development of therapies for the coronavirus

β€œViruses like COVID-19 spread rapidly, but the development of vaccines and treatments to stop them moves slowly,” said Mark Suzman, chief executive officer of the Bill & Melinda Gates Foundation.

β€œIf we want to make the world safe from outbreaks like COVID-19, particularly for those most vulnerable, then we need to find a way to make research and development move faster."

The Accelerator will have an end-to-end focus, from drug pipeline development through manufacturing and scale-up. By sharing research, coordinating investments, and pooling resources, these efforts can help to accelerate research.

This kind of collaboration was a key lesson from the 2014 Ebola outbreak.

By providing fast and flexible funding at key stages of the development process, the Accelerator will de-risk the pathway for new drugs and biologics for COVID-19 and future epidemic threats, ensuring access in lower-resource countries.

JOIN OUR PREMIUM MEMBERSHIP TODAY

By becoming a premium member, you'll have full access to all content and be supporting the Warp News non-profit foundation and our efforts to spread fact-based optimism all over the world.

You've successfully subscribed to Warp News
Great! Next, complete checkout for full access to Warp News
Welcome back! You've successfully signed in.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info is updated.
Billing info update failed.